Emerging from stealth, Octant is bringing the tools of synthetic biology to large scale drug discovery

May 20, 2020

Study will evaluate the safety, tolerability and pharmacokinetics (PK) of OCT-980 in healthy volunteers

Initiation of the study marks Octant’s transition to a clinical-stage company

Download resourceBack to all News